期刊
DRUG DEVELOPMENT RESEARCH
卷 56, 期 3, 页码 491-510出版社
WILEY-LISS
DOI: 10.1002/ddr.10100
关键词
GSK-3 beta; tau; APP; kinesin; amyloid-beta; insulin; neurofibrillary tangles; phosphatase; pro-apoptosis
Glycogen synthase kinase 3beta (GSK-3beta) is an important regulatory kinase involved in multiple processes such as metabolic control, embryonic development, cell death, and oncogenesis. It has been found to interact with many molecules associated with Alzheimer's disease (AD) such as the microtubule-associated protein tau, presenilin 1, the amyloid-beta peptide, the amyloid precursor protein, and acetylcholine. Furthermore, GSK-3beta might be involved in brain aging and longevity. As GSK-3beta is associated with so many components of AD pathology, we review the current data on the role of this kinase in tau hyperphosphorylation, then look at its association with AD-related molecules and pathways, and finally discuss its involvement in cell death and aging. We attempt to integrate all these data to arrive at the proposition that GSK-3beta is a pivotal molecule in the evolution of AD and that developing drugs directed at this kinase might prove to be beneficial in the treatment of this devastating disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据